Category: Research

How much are we moving? Where are we going? Before COVID-19 arrived in Wisconsin, UW-Madison Assistant Geography Professor Song Gao was exploring those questions.

Similarly, Bharat Biotech has partnered with the University of Wisconsin, Madison, and the US-based company FluGen to develop a vaccine, Coro-Flu.

Many Floridians appear to have reached a similar conclusion. Analysis of cellphone location data by companies like Descartes Labs Inc. and SafeGraph Inc. shows that residents’ daily mobility began dropping sharply after March 15, as it did in other parts of the U.S. By the following week, it had declined more than 50% statewide from an established baseline, according to a compilation of such data by a lab at the University of Wisconsin-Madison. In Miami-Dade and Broward counties, it had decreased more than 80%.

By using tests from infected patients, UW-Madison Professor Dr. Thomas Friedrich is tracking the genetic sequences of the coronavirus, which provides scientists with a better understanding of the virus.

Those theories also found support in Harlow’s monumental research with baby monkeys in a University of Wisconsin laboratory.

Most Wisconsinites have complied with social distancing, despite protests in Madison last week.

Thomas Friedrich, professor of pathobiological sciences in the School of Veterinary Medicine, and his team at UW-Madison are tracking how the coronavirus changes, ever so slightly, as it moves from person to person.

A group of researchers at the University of Wisconsin-Madison used data from multiple vendors to estimate the impact of in-person voting on movement patterns during Wisconsin’s election on April 7.

CoroFlu, being developed under an international collaboration, is built on the backbone of FluGen’s flu vaccine candidate known as M2SR. Based on an invention by the University of Wisconsin-Madison virologists and FluGen co-founders Yoshihiro Kawaoka and Gabriele Neumann, M2SR is a self-limiting version of the influenza virus that induces an immune response against the flu.

Treatment reserved for patients life-threateningly ill, severe symptoms.

Treatments involve application of mass spectrometry techniques.

The study was published by the University of Wisconsin School of Medicine and Public Health (SMPH) on April 22 in the Journal of Allergy and Clinical Immunology.

Data is given to local public health officials to help decide personal protective equipment allocation.

They developed pneumonia-like symptoms but no serious fever. Virologist David O’Connor of the University of Wisconsin-Madison and his team tried to simulate an illness comparable to that of a severely ill human, according to Nature.

Bharat Biotech in Hyderabad had announced a partnership with the University of Wisconsin Madison and US-based firm FluGen for the manufacture of almost 300 million doses of vaccine for global distribution.

In Hyderabad, Bharat Biotech is collaborating with virologists at the University of Wisconsin (UW)-Madison and vaccine company FluGen on a “unique intranasal vaccine” called CoroFlu.

Early results from the research indicate the speed of viral transmission has slowed since Gov. Tony Evers issued the first Safer at Home order on March 25. UW-Madison said this shows, in the absence of other options, social/physical distancing is necessary to stop the spread of the coronavirus.

In fact, DHS data shows that the number of infections has been rising by about 150 to 190 cases per day, doubling about every two weeks, according to calculations posted by professor Brian Yandell, interim director of the American Family Insurance Data Science Institute at the University of Wisconsin-Madison. As of Monday afternoon, DHS reported 4,449 people with positive tests for the infection, including 230 people who have died.

“People have been studying the solar wind since its discovery in 1959, but there are many important properties of this plasma which are still not well understood,” says physicist Stas Boldyrev from the University of Wisconsin–Madison.

n a 2013 observational study of the large-scale structure of the universe, University of Wisconsin-Madison astronomers Amy Barger and Ryan Keenan showed that our galaxy, in the context of the large-scale structure of the universe, resides in an enormous void—a region of space containing far fewer galaxies, stars and planets than expected. The structure of the cosmos is Swiss cheese-like in the sense that it is composed of “normal matter” in the form of voids and filaments.

Philip Townsend, an ecologist at the University of Wisconsin, Madison, has been working to turn those measurements into easy-to-use maps. He’d planned to groundtruth his efforts by collecting leaves this season. But this spring, there will be both airborne measurements and leaf collection are on hold.

Among Indian companies, Bharat Biotech Ltd is reportedly partnering with University of Wisconsin-Madison and US-based FluGen to develop a vaccine while Zydus Cadila and Serum Institute, too, are working for a vaccine

Research provides information on social distancing, transmission of virus.

The map created by the GeoDS Lab at the University of Wisconsin-Madison, tracks the movement of Americans, using anonymous location data from cell phones.

Amidst the COVID-19 pandemic, a team of researchers at the University of Wisconsin-Madison is using a tool to estimate just how much people have cut back on travel, which is data that can be used to inform the response to the virus.

“We still need to understand how the virus behaves in different species, and which questions are best answered by which species,” said Dave O’Connor, a pathologist at the University of Wisconsin-Madison who is leading some of the first research in the US on Covid-19 in monkeys. Here are a few playing a primary role in current research.

Dave O’Connor of the University of Wisconsin, Madison, who is studying SARS-CoV-2 in cynomolgus monkeys, says the field will ultimately winnow down models. “It might turn out that some models are not really worth pursuing after we do this sort of foundational work, but I just don’t think we’re there yet. We need to let the data guide us.”

“Bharat Biotech had approached us for preclinical studies but we did not have the animals,” says Pothani. Now these are being carried out in University of Wisconsin-Madison. The same is true for the vaccine developed by Serum Institute of India and Codagenix, Inc. is also being tested in the USA. Pothani reveals that the institute has requested the secretary to import the animals to ensure future studies.

If things go according to plan, human trials could start by August.

On the case is the somewhat facetiously named Unionid Mussel Strike Force, a collaboration of two researchers at the University of Wisconsin-Madison and a half-dozen other scientists from a handful of federal agencies around the country. But in addition to trying to solve a mystery, the Strike Force is struggling against another obstacle long familiar to mussel specialists: apathy.

Goldwater scholarships recognize excellence in undergraduate research.

The effort is in collaboration with the United Auto Workers union, the Iowa Department of Homeland Security and the Illinois Manufacturers’ Association. The company said it’s using an open-source design from the University of Wisconsin-Madison for the project.

Some of the most serious and critically ill will be offered the chance to be treated with the blood of those who have recovered from the virus.

UW research lab works to modify chicken coronavirus vaccine to create DNA based vaccine for human coronavirus.

An effort led by the others in the DES team, including former KIPAC students Alex Drlica-Wagner, a Wilson Fellow at Fermilab and an assistant professor of astronomy and astrophysics at the University of Chicago, and Keith Bechtol, an associate professor of physics at the University of Wisconsin-Madison, and their collaborators produced the crucial final step: a model of which satellite galaxies are most likely to be seen by current surveys, given where they are in the sky as well as their brightness, size, and distance.

In India, Hyderabad-based vaccine manufacturer, Bharat Biotech, which has been working on developing a intra-nasal drop vaccine for COVID-19, has initiated testing in the US in collaboration with the University of Wisconsin-Madison and vaccine developer FluGen, CNBC-TV18 reported.